Sessions & Presentations

Title Time Appointment
Cirrhosis and its complications (1): Portal Hypertension
Poster area
23. June 2021, 08:00 AM - 06:00 PM More ...
Cirrhosis and its complications (3): Other clinical complications except ACLF and critial illness
Poster area
23. June 2021, 08:00 AM - 06:00 PM More ...
Cirrhosis and its complications (4): Experimental and pathophysiology
Poster area
23. June 2021, 08:00 AM - 06:00 PM More ...
Cirrhosis and its complications (2): ACLF and Critical illness
Poster area
23. June 2021, 08:00 AM - 06:00 PM More ...
PGC: Lifestyle and the liver - Impact of physical activity and diet on liver disease
Metabolism, Alcohol and toxicity
23. June 2021, 11:15 AM - 12:15 PM More ...
Research Think Tank: Liver Transplantation in patients with Acute on Chronic Liver Failure - a call to action
Cirrhosis and complications
24. June 2021, 08:00 AM - 09:30 AM More ...
Research Think Tank: Focal lesions at the crossroads of vascular liver diseases
General Hepatology
24. June 2021, 08:00 AM - 09:30 AM More ...
Meet the Experts: Portopulmonary hypertension - new management
Meet the Experts 1
24. June 2021, 10:00 AM - 10:50 AM More ...
Abstract session: Experimental cirrhosis and gut-liver axis
Cirrhosis and complications
24. June 2021, 10:00 AM - 11:30 AM More ...
Managing intrahepatic cholangiocarcinoma
Liver Tumours
24. June 2021, 02:00 PM - 03:00 PM More ...
Old and new treatments for patients with advanced cirrhosis
Cirrhosis and complications
24. June 2021, 02:00 PM - 03:00 PM More ...
Porto-sinusoidal vascular disease: what is behind this new name?
General Hepatology
24. June 2021, 02:00 PM - 03:00 PM More ...
ePoster session: Acute liver failure, DILI, ACLF and critical illness, liver transplantation and hepatobiliary surgery
Other 2
24. June 2021, 03:00 PM - 04:00 PM More ...
Abstract session: Cirrhosis and portal hypertension
Cirrhosis and complications
25. June 2021, 08:00 AM - 09:30 AM More ...
How to use statistics for research in liver diseases
General Hepatology
25. June 2021, 10:00 AM - 11:00 AM More ...
Sinusoidal cells in chronic liver disease
Cirrhosis and complications
25. June 2021, 10:00 AM - 11:00 AM More ...
Meet the Experts: Abdominal surgery in patients with portal hypertension - Risks and complications
Meet the Experts 1
25. June 2021, 10:00 AM - 10:50 AM More ...
ePoster session: Cirrhosis and its complications - Portal hypertension
Cirrhosis and complications
25. June 2021, 11:30 AM - 12:30 PM More ...
Abstract session: Complications of cirrhosis
Cirrhosis and complications
25. June 2021, 02:00 PM - 03:30 PM More ...
ePoster session: Cirrhosis and its complications & Immune-mediated and cholestatic disease - Experimental and pathophysiology
Cirrhosis and complications
25. June 2021, 03:30 PM - 04:00 PM More ...
EASL-ISTH: Vascular liver disease board: DOAC and Liver disease
Cirrhosis and complications
26. June 2021, 08:00 AM - 09:00 AM More ...
Meet the experts: TIPS: when to use and when not to use
Meet the Experts 1
26. June 2021, 08:00 AM - 08:50 AM More ...
Nurses and AHP Forum: Case Study - Challenges in person-centred care in cirrhosis
Other
26. June 2021, 09:00 AM - 10:05 AM More ...
ePoster session: Cirrhosis and its complications - Other clinical complications except ACLF and critial illness
Cirrhosis and complications
26. June 2021, 09:00 AM - 10:00 AM More ...
Abstract session: ACLF and liver transplantation
Cirrhosis and complications
26. June 2021, 10:00 AM - 11:30 AM More ...
Debate in hepatology: Is the term and the concept of ACLF useful in clinical practice?
Cirrhosis and complications
26. June 2021, 02:00 PM - 03:00 PM More ...
Drivers of outcome in compensated alcohol-related cirrhosis: a prospective study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Has the 5-year mortality of patients with alcoholic cirrhosis changed during the last 20 years ?
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Acamprosate for the treatment of alcohol use disorder may be safer than baclofen in patients with cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
A scoring model to predict mortality in hospitalized patients with decompensated cirrhosis and hyponatremia
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Emergency room care is essential in improving outcomes of decompensated cirrhosis patients: A Canadian experience
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Timing of endoscopy for acute variceal bleeding in patients with cirrhosis (CHESS1905): a nationwide cohort study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
In-hospital mortality after surgery in patients with liver cirrhosis: A nationwide study of 1,662,887 patients
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Metamizole intake is associated with acute kidney injury and a higher mortality in patients with decompensated liver cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Risk stratification based on liver stiffness and platelets for decompensation events in patients with compensated cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Beta-blockers to prevent decompensation of cirrhosis: an emulation of the PREDESCI trial
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Application of a machine learning model to improve performance of endoscopic classification for prediction bleeding in patients with compensated cirrhosis with esophageal varices
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Carvedilol improves risk of decompensation and survival in compensated cirrhosis. A competing-risk meta-analysis of individual patient data
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Clinical decompensation and outcomes in patients with biopsy proven cirrhosis and a hepatic venous pressure gradient <= 10 mm Hg
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Influence of Shunt occlusion on Organ Functions in Hyperammonemic patients with Cirrhosis having Porto-systemic Shunt: a randomized controlled trial
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Prognostic impact of Hepatic venous pressure gradient cut-off of 10mm Hg to predict clinical decompensations in patients with compensated cirrhosis with liver stiffness above 25 kilopascals
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Effects and safety of atrial natriuretic peptide administered to cirrhosis patients with ascites: a systematic review and meta-analysis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Umbilical hernia repair in Cirrhosis: TIPS insertion improves one-year survival but not long-term outcomes
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Plasma Soluble CD14 predicted development of hospital acquired infection in decompensated cirrhosis patients from the ATTIRE trial
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Potential mechanisms underlying the protective effect of long-term albumin infusion in cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Stem Cell Transplantation in patients with cirrhosis and acute-on-chronic liver failure: A randomized, double-blind placebo control trial.
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Intestinal epithelial cell signalling and cell death in Cirrhosis and Acute-on-Chronic Liver Failure
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
CLIF-SOFA accurately predicts in-hospital mortality in patients with cirrhosis and bacterial infection
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Non-malignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Improved survival and reduced risk of hospital admissions after 12-weeks of resistance training in patients with cirrhosis - a three year follow-up from randomization
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Baveno-VI criteria to predict variceal bleeding and liver decompensation in compensated cirrhosis patients
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
prognostic impacts of the change in muscle mass on patients with cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Safety of 11,043 paracentesis in patients with liver cirrhosis with and without anticoagulant treatment. Large, retrospective, unicentric study.
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Further analysis of simvastatin safety trial in patients with decompensated cirrhosis provides promising information about improving liver function and reducing cirrhosis severity
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Evaluation of cardiac function in cirrhosis across different prognostic stages; A focus on plasma biomarkers of fibrosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Epidemiology of spontaneous bacterial peritonitis and bacterascites in patients with cirrhosis in Queensland, Australia from 2008-2017
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Cirrhocare - a pilot study of digital home-monitoring of advanced cirrhosis to determine feasibility and utility to diagnose new decompensation events.
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Myostatin is associated with sarcopenia and in combination with creatinine phosphokinase or albumin may be used as a screening tool of sarcopenia in liver cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Circulating microRNAs profiling in acute decompensation of liver cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Low incidence of SARS-CoV-2 infection in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a German tertiary center during the 2020 pandemic
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Baseline liver volume is a major prognostic factor in acute decompensation of alcohol-associated cirrhosis: results from the prospective multicentre PROLIV study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
High risk medication-related problems are associated with lower quality of life in decompensated cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Albumin dysfunction correlates with disease markers in patients with decompensated cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
A study evaluating outcomes of cirrhotic patients managed virtually in a specialist liver cirrhosis service due to the COVID crisis.
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Validation of a novel point-of-care test for gut leakage in cirrhosis based on dimeric to monomeric IgA ratio: a pilot cohort study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Hepatogenous diabetes in patients with cirrhosis and ascites: correlation with inflammatory activity, systemic hemodynamics, renal function, and outcome
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
An educational intervention that effectively reduces the inappropriate administration of proton pump inhibitors in patients with cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Transcriptomic profiling of liver sinusoidal endothelial cells during cirrhosis progression reveals stage-specific secretory signature
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Hepatic fat loss in cirrhosis: Evaluation of malnutrition using MRI proton density fat fraction (MRI-PDFF)
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Systemic and hepatic endothelial cell activation biomarkers expression are associated with inflammation and disease progression in patients with cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
PNPLA3-associated cirrhosis: HSD17B13 and MBOAT7 variants as modulators of chronic liver injury.
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
SLEEP STUDY WITH ACTIGRAPHY IN PATIENTS AFFECTED BY CIRRHOSIS WITH AND WITHOUT MINIMAL HEPATIC ENCEPHALOPATHY
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Markers of neutrophil extracellular traps are elevated in patients with Child-Pugh B and C liver cirrhosis or large hepatocellular carcinomas
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Rifaximin and Fecal Microbiota Transplant beneficially modulate gut metagenomic virulence factors in cirrhosis: Analysis of two trials
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Rifaximin suppresses gut-derived systemic inflammation and promotes a gut microenvironment with reduced mucin degradation conducive to gut barrier repair in patients with cirrhosis and hepatic encephalopathy
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Incidence of hepatic outcomes in patients with cirrhosis due to primary biliary cholangitis: A population-based epidemiology study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Among cancer patients, autoimmune hepatitis with cirrhosis increases mortality
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Blood-derived extracellular vesicles of patients with liver cirrhosis and acute-on-chronic liver failure display immunomodulatory functions
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Liver transplantation for NAFLD cirrhosis : early overall patient survival is good
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Disease recurrence after liver transplantation for NAFLD cirrhosis : just wait!
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Impact of bacterial infections prior liver transplantation on post-transplant outcomes in patients with cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Cirrhosis regression based on both Enhanced Liver Fibrosis (ELF) and Fibrotest after direct-acting hepatitis C therapeutics corresponded to a lower incidence rate of hepatocellular carcinoma (HCC) below the cost-effective threshold for surveillance
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Diagnostic and prognostic value of miR-16, miR-146a and miR-192 in exosomes of hepatocellular and liver cirrhosis patients
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Multibipolar radiofrequency ablation versus liver resection for the treatment of hepatocellular carcinoma within Milan criteria developed on advanced fibrosis/cirrhosis: a multicentric study on 1060 patients
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Low alcohol consumption is associated with a decreased frequency of cirrhosis and hepatocellular carcinoma in a cohort of NAFLD outpatients
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Frailty in non-alcoholic fatty liver cirrhosis in comparison to alcoholic cirrhosis, risk patterns and impact on prognosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
MAFLD-related cirrhosis is the main contributor to admissions for decompensated cirrhosis in intensive care unit. A single-center, 18-month experience.
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Derivation and validation of the NAFLD cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis and to predict liver-related outcomes
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Independent validation of Agile 4: novel FibroScan based score for the diagnosis of cirrhosis in patients with non-alcoholic fatty liver disease
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
A deep learning approach to analysis of MRCP images predicts clinical events and progression to cirrhosis in patients with primary sclerosing cholangitis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Development and multicenter external validation of FIB-6; a novel, machine-learning, simple bedside score to rule out severe liver fibrosis and cirrhosis in patients with chronic hepatitis C
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Patients with LIVER CIRRHOSIS - SATISFACTION in a NURSE-LED outpatient clinic
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Randomized controlled study:ınvestıgation of the effcet of exercise on liver function tests,fatigue and quality of life in patients with liver cirrhosis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Performance of screening strategies for primary prophylaxis of variceal bleeding in patients with compensated cirrhosis: a cost-effectiveness analysis
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Epidemiological evaluation of the liver cirrhosis in Albania: comparison with the historical data and indications to  antiviral treatment appropriateness
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
SEAL program - Early detection of liver fibrosis and cirrhosis by screening of the general population
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Etiology of Cirrhosis in Turkey: A National Cohort Study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
An episode of detectable serum hepatitis B  virus-DNA level does not affect risk of hepatic decompensation among untreated compensated cirrhosis patient with viral load of < 2,000 IU/mL
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Detection of novel biomarkers in HBV-associated chronic hepatitis, liver fibrosis/cirrhosis, and hepatocellular carcinoma utilizing transcriptome sequencing technology
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Excellent virological and clinical responses maintained over 3 years of continuous Bulevirtide treatment in patients with HDV compensated cirrhosis and clinically significant portal hypertension
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
The incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis during long-term antiviral therapy: A real world cohort study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Hepatitis C virus eradication improves cognition in patients with and without cirrhosis: results from a real-life prospective study.
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Patients with cirrhosis show an improvement in dynamic liver function following the eradication of hepatitis C virus with direct acting antivirals
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
High prevalence of hormonal changes and hepatic osteodystrophy in Frail patients with cirrhosis An observational study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Improving the Accuracy of Non-Invasive Tests for Prediction of Cirrhosis in Chronic Hepatitis Delta: Insights from 230 Patients of the D-LIVR Study
Poster area
23. June 2021, 08:00 AM - 08:00 AM More ...
Patients with cirrhosis should exercise!
Metabolism, Alcohol and toxicity
23. June 2021, 11:40 AM - 11:50 AM More ...
Virulence factors in gut metagenomics worsen with disease progression and predict outcomes in cirrhosis
Cirrhosis and complications
24. June 2021, 10:00 AM - 10:15 AM More ...
Incidence rates of select outcomes among patients with non-alcoholic steatohepatitis (NASH) and evidence of fibrosis or cirrhosis
Metabolism, Alcohol and toxicity
24. June 2021, 10:15 AM - 10:30 AM More ...
Faecal microbiota transplantation improves intestinal barrier function and modulates mucosal IL-17 immunity in patients with advanced cirrhosis
Cirrhosis and complications
24. June 2021, 10:30 AM - 10:45 AM More ...
In-depth shotgun metagenomic analysis of the gut microbiome identifies striking variations in microbial community structure based on severity and stage of cirrhosis
Cirrhosis and complications
24. June 2021, 11:15 AM - 11:30 AM More ...
How to treat an early stage lesion in a patient without/with cirrhosis?
Liver Tumours
24. June 2021, 02:00 PM - 02:10 PM More ...
Estimating the contribution of viral hepatitis and other etiologies to the burden of cirrhosis: a worldwide systematic review
Cirrhosis and complications
25. June 2021, 09:00 AM - 09:15 AM More ...
Anticoagulation improves overall survival through portal vein recanalization in patients with cirrhosis and portal vein thrombosis: Individual patient data meta-analysis (IMPORTAL study)
Cirrhosis and complications
25. June 2021, 09:15 AM - 09:30 AM More ...
The clinical course of COVID-19 in patients with cirrhosis
Immune-mediated and cholestasis
25. June 2021, 10:00 AM - 10:10 AM More ...
Covered transjugular intrahepatic portosystemic shunt implantation improves renal function in patients with cirrhosis and ascites
Cirrhosis and complications
25. June 2021, 02:00 PM - 02:00 PM More ...
Sex is a major effect modifier on the association between body composition and mortality in patients with cirrhosis assessed for liver transplantation
Cirrhosis and complications
25. June 2021, 02:00 PM - 02:00 PM More ...
Branched chain amino acids do not improve muscle mass in patients of cirrhosis with sarcopenia: A double blind randomized placebo controlled trial
Cirrhosis and complications
25. June 2021, 02:00 PM - 02:00 PM More ...
Targeted albumin therapy increases serum sodium in hospitalized cirrhosis patients with hyponatremia at baseline, but has no effect on short term outcome; a sub study from the ATTIRE Trial
Cirrhosis and complications
25. June 2021, 02:00 PM - 02:00 PM More ...
Role of DOACS in management of thrombotic complications in patients with cirrhosis
Cirrhosis and complications
26. June 2021, 08:30 AM - 08:45 AM More ...
A randomized trial of albumin infusions in hospitalized patients with cirrhosis
Other 2
26. June 2021, 10:00 AM - 10:00 AM More ...
Suffering from the unpredictable illness in liver cirrhosis
Other
26. June 2021, 10:15 AM - 10:35 AM More ...
Treatment of iron deficiency anemia with intravenous ferric carvoxymaltose imroves significantly systemic hemodynamics, renal function, and survival in patients with cirrhosis and ascites
General Hepatology
26. June 2021, 12:45 PM - 01:00 PM More ...
Efruxifermin (EFX) improved markers of fibrosis, liver injury and metabolism in F4 NASH patients with compensated cirrhosis
General Hepatology
26. June 2021, 01:00 PM - 01:15 PM More ...
Bile acid signaling and liver cirrhosis
Liver Tumours
26. June 2021, 02:00 PM - 02:10 PM More ...
Cirrhosis
General Hepatology
26. June 2021, 05:00 PM - 05:15 PM More ...